EGFR and non-small cell lung carcinoma: Moreover, although surgical resection is considered a preferred treatment in early-stage NSCLC, a retrospective study held in Japan showed a 19.7% recurrence rate after complete surgical resection, with EGFR mutations being an independent risk factor for recurrence [22].